Paraneoplastic endocrine-metabolic syndromes

BACKGROUND The paraneoplastic syndromes (PS) are characterized by the presence of biochemical alterations, signs and symptoms expressive of cancer distance action into the patient’s organism. Sometimes these syndromes can precede the evidence of malignancy even of some years or can correspond to can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Italian journal of medicine 2013-04, Vol.3 (1), p.19-29
Hauptverfasser: Grandi, Marco, Sacchetti, Carla, Pederzoli, Stefano, Torri, Cinzia, Sgarbi, Ilaria, Partesotti, Giovanni, Nicolini, Massimiliano, Casarini, Chiara, Romagnani, Elena, Benatti, Chiara, Vecchi, Federica, Gollini, Claudio, Manni, Bruno, Sirotti, Giacinto, Leone, Maria Ernesta, Pasqualini, Rita, Pedrazzi, Antonio
Format: Artikel
Sprache:eng ; ita
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND The paraneoplastic syndromes (PS) are characterized by the presence of biochemical alterations, signs and symptoms expressive of cancer distance action into the patient’s organism. Sometimes these syndromes can precede the evidence of malignancy even of some years or can correspond to cancer relapse. PS, even being characterized by general symptoms (fever, anorexia, cachexia), may occur with neurological, rheumathological, osteoarticular, vascular, haematological, nephrological and endocrinological/metabolic symptoms; the latter ones are discussed in this article. AIM OF THE STUDY Here we will focus on the most common PS: paraneoplastic hypercalcemia, inappropriate secretion of antidiuretic hormone (SIADH) and paraneoplastic Cushing syndrome. CONCLUSIONS Our work can be useful in the diagnosis and therapeutic management of paraneoplastic syndromes.
ISSN:1877-9344
1877-9352
DOI:10.4081/itjm.2009.19